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Abstract
Original Article
IntroductIon
Stereotactic body radiation therapy (SBRT) is a leading 
treatment modality, especially for early-stage nonsmall cell 
lung cancer. SBRT involves small size radiation fields with 
sharp dose falloff and image-guided localization.[1] Potential 
advantages of SBRT include a higher biological effective dose 
and greater delivery efficiency with volumetric-modulated arc 
therapy (VMAT).[2,3] Similar to intensity-modulated radiation 
therapy (IMRT), RapidArc planning technique in Eclipse 
treatment planning system (Varian Medical Systems, Palo 
Alto, CA, USA) based on VMAT has the ability to produce 
conformal dose distribution around the target, reducing dose 
to organs at risk (OAR).[4-8]
In plan evaluation, metrics such as volume of normal lung 
irradiated by 20 Gy (V
20
) present an incomplete view of the 
dose falloff to the normal tissue. R
50%
 and D
2cm
 were used to 
assess the intermediate-to-low dose spillage outside the PTV. 
HDloc was recommended to evaluate the high-dose (>105%) 
spill outside the PTV. However, both R
50%
 and D
2cm
 could 
include regions outside the lung tissue or ribs that may not 
have known dose tolerance or clinical end-points. Conversely, 
D
2cm
 is estimated isotropically at 2 cm distance from PTV 
surface without taking water equivalent path length into 
account. In this study, we have identified a trend in the R
50%
 
and D
2cm
 data questioning their independence that is worth 
Introduction: Radiation Therapy Oncology Group (RTOG) report #0813 and 0915 recommends using D
2cm
 and R
50%
 as plan quality metrics 
for evaluation of normal tissue sparing in stereotactic body radiation therapy (SBRT) of lung lesion. This study introduces dose falloff 
gradient (DFG) as a tool for analyzing the dose beyond the planning target volume (PTV) extending into normal tissue structures. In ascertaining 
the impact of PTV size and SBRT planning techniques in DFG, this study questions the independence of the RTOG recommended metrics. 
Materials and Methods: In this retrospective study, 41 RapidArc lung SBRT plans with 2 or 3 complete or partial arcs were analyzed. PTV 
volumes ranged between 5.3 and 113 cm3 and their geographic locations were distributed in both lungs. 6MV, 6 MV-FFF, 10 MV, or 10 MV-FFF 
energies were used. RTOG-0915 metrics conformity index, homogeneity index, D
2cm
, R
50%
, and HDloc were evaluated. DFG was computed 
from the mean and maximum dose in seven concentric 5 mm wide rings outside the PTV. DFG was investigated against the volume of normal 
lung irradiated by 50% isodose volume. Treatment plans with alternate energy and couch rotations were generated. Results: The dose falloff 
beyond PTV was modeled using a double exponential fit and evaluated for relationship with intermediate lung dose. Photon energy and beam 
configuration had a minimal impact on the dose falloff outside. The product of normalized D
2cm
 and R
50%
 was estimated to have a slowly 
varying value. Conclusions: Dose falloff outside PTV has been studied as a function of radial distance and ascertained by intermediate dose 
to normal lung. DFG can serve as a complementary plan quality metric.
Keywords: Dose falloff, dose gradient, lung stereotactic body radiation therapy, stereotactic body radiation therapy dose falloff, 
stereotactic body radiation therapy planning
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exploring. In addition, neither of these metrics could correlate 
with the excessive toxicity observed when treating central 
lung tumors using SBRT.[9] In this study, we propose to study 
the normal tissue toxicity using exponential dose falloff 
gradient (DFG)[10] that can be directly related to the normal 
lung volume irradiated. To study the impact of planning 
techniques on the dose falloff, plans with alternate coplanar/
noncoplanar arc configuration and alternate photon energy 
were also utilized.
MaterIals and Methods
Patient data
This study was approved by the institutional review 
board. Forty-one lung tumor patients previously treated 
with VMAT-based SBRT were included in this study. 
Four-dimensional computed tomography (4D-CT) scanning 
was performed in GE-Discovery CT scanner (GE Medical 
Systems, Waukesha, WI, USA) and CT images were 
reconstructed at 2 mm slice spacing. The 4D-CT image data 
were sorted into 10 phase bins ranging from 0% to 90% with 
0% phase being end-inspiration and 90% phase end-expiration. 
The maximum intensity projection images were used in 
generating an internal target volume (ITV). ITV is grown into 
PTV anisotropically using 10, 5, and 5 mm margins along 
longitudinal, lateral, and anterior-posterior axes, respectively. 
Table 1 shows the patient statistics.
VMAT-based SBRT plan was  calcula ted on the 
respiration-averaged CT of the ten phases of 4D-CT using 
Acuros XB dose calculation algorithm on Eclipse treatment 
planning software version 11.0 (Varian Medical System, Palo 
Alto, CA, USA). RapidArc technique was used for delivery 
on either a Novalis Tx or a TrueBeam™ STx equipped with 
high-definition multileaf collimators. SBRT plans were 
created using either 2 or 3 complete or partial arcs based on 
6MV, 6 MV-FFF, 10 MV, or 10 MV-FFF energies. Coplanar 
or noncoplanar field configuration with up to ± 15° couch 
rotation was generated.
Plans were normalized such that 95% of PTV received the 
prescription dose (Rx) of 48–55 Gy. Among the 41 clinical 
plans, 35 plans involved couch rotations ranging between 0° 
and 30° with a mean ± standard deviation (SD) of 16.1° ± 9.8°. 
Dose constraints to the OARs include maximum point dose of 
18 Gy to spinal cord, 30 Gy to heart, 24 Gy to brachial plexus, 
30 Gy to trachea, and a mean dose of 27 Gy to esophagus as 
well as maximum percent V
20
 of 15%. Dose calculation grid 
size was set at 2 mm for SBRT at our institution.
Thorax phantom study
A phantom study was contrived to (a) study the asymmetrical 
spread in spatial dose distribution around the lung tumor 
number and (b) identify the optimum width of rings outside the 
PTV for dose falloff calculations. While the former is intended 
to address the predominantly coplanar dose distribution due 
to large fraction of coplanar beams in our clinical plans, 
the latter facilitates dose evaluation outside PTV in a lung 
SBRT plan. The steep dose falloff along the longitudinal 
axis was known to skew the spatial dose distribution and a 
“ring terminator” region can be considered similar to setting 
a low-dose threshold. The longitudinal and lateral extents of 
the “ring terminator” region are identified using linear dose 
profile measurement. While thin rings may explore dose falloff 
accurately, they could be impaired by noise fluctuations. On the 
other hand, wider rings may suffer from low spatial resolution. 
The slope of mean and maximum dose falloffs and the rate of 
change of slope that corresponds to curvature were computed. 
These measurements were compared for the four ring sizes 
considered here, 2.5 mm, 5 mm, 7.5 mm, and 10 mm width.
A thorax phantom (Model 002 LFC; CIRS Inc., Norfolk, VA, 
USA) with spherical lung lesions varying between 5, 10, 20, 
40, and 80 cm3 was used in this study. A VMAT SBRT plan was 
created for each target meeting the clinical dose coverage. The 
target coverage, dose conformity, and mean and maximum dose in 
the rings were evaluated in addition to the proposed metric, DFG.
Radiation Therapy Oncology Group plan quality metrics
Radiation Therapy Oncology Group (RTOG) report #0915 
treatment plan quality metrics include the conformity 
index (CI) of the target coverage which is defined as the ratio 
of prescription isodose volume to the volume of PTV.
CI PIV
PTV
= �  (1)
Dose homogeneity index (HI) within the target can be 
estimated using the ratio of differences between the doses 
delivered to 2% and 98% of volume with the median dose to 
the PTV, which was originally proposed in ICRU-83.[11]
HI
D D
D
=
−( )2 98
50
% %
%
 (2)
For estimation of dose falloff outside the target, RTOG 
recommended metrics evaluated include R
50%
, D
2cm,
 and HDloc.
Table 1: The maximum, minimum, average and 
standard deviation of Rx dose (Gy), number of MUs, 
normalization (%), planning target volume (cm3), 
equivalent diameter (cm), number of arcs, total gantry 
span, and total couch span of the 41 lung tumor 
stereotactic body radiation therapy patient plans
Maximum Minimum Average SD
Rx dose (Gy) 55 48 49.3 1.75
Total MU 27712 10194 16065.0 3383.4
Normalization (%) 94 62 76.5 14.1
Volume of PTV (cm3) 112.7 5.3 30.9 26.4
PTV equivalent 
diameter (cm)
6 2.2 3.63 1.0
# arcs 3 2 2.2 0.4
Total gantry rotation 
span (°)
716 388 509.1 119.0
Total couch rotation 
span (°)
30 0 16.1 9.8
PTV: Planning target volume, SD: Standard deviation
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R Rx isodose volume
PTV Volume50
50
%
%
=  (3)
D
2cm
 is defined as the maximum dose (in % of prescribed 
dose) at a point 2 cm away from the surface of PTV along 
any direction. For estimation of high-dose spillage (HDloc), 
volume of 105% isodose volume outside the PTV is estimated 
as a ratio of the volume of PTV.
HD Rx isodose volume outside PTV
PTV Volumeloc
=
105%
 (4)
Published tables provide desirable range of values for these 
metrics.[12] Dose falloff product (DFP) defined as the product 
of D
2cm
 and R
50%
 was introduced to study the dependence of the 
two metrics (D
2cm
 and R
50%
) on one another by investigating 
the relationship between DFP and PTV. An SBRT plan of 
high quality would have low values for R
50%
, D
2cm
, HDloc as 
well as DFP.
Dose falloff
In evaluating IMRT and VMAT plans, the peripheral dose to 
the OARs may need the spatial dose distribution in addition to 
dose–volume histogram (DVH) statistics. The proposed dose 
falloff was modeled as a double exponential fit of the radial 
distance (r) from the PTV surface in the form:
%DD r A e A ea r a r( ) = +− −1 21 2  (5)
where A1, a1, A2, and a2 refer to fitting coefficients and 
%DD (r) denotes the dose as a percent of the Rx at a radial 
distance r (mm) from PTV. Value of the coefficients was 
obtained using the statistics toolbox in Matlab ver R2016a 
(The Mathworks, Inc., Natick, MA, USA). The first and 
second terms in Equation 5 represents steep and shallow 
exponential dose falloff. Notice that as r approaches 0, 
the first term dominates and as r approaches large clinical 
distances, the second term dominates. By definition, steep 
DFG is numerically equal to a1 and the shallow DFG is 
a2. A large DFG implies fast dose falloff outside PTV and 
less volume of normal lung tissue irradiation which holds 
significance in our study. The relationship between DFG 
and the 50% isodose volume irradiating the normal lung 
(outside PTV and not including the chest wall or ribs) is 
studied on the patient plans.
Alternate planning strategy
The aim of the alternate planning strategies was to study any 
reduction in dose to normal tissue in addition to improved 
RTOG metrics. Alternate research plans utilize two strategies. 
In the first method, all noncoplanar beams were changed to 
coplanar beams, and dose was computed after plan optimization 
for coplanar beam arrangement. This would test the hypothesis 
that the altered footprint of radiation passing through the 
patient’s body would change the low and intermediate dose 
levels. Papiez et al. had postulated steep dose falloff from 
multiple noncoplanar, nondivergent beams in extracranial 
stereotactic radioablation.[13] While the authors attempted to 
“imitate” Gamma Knife treatments using linear accelerator for 
extracranial sites, there was limited clinical feasibility.
The use of FFF beams with cone-shaped profile could alter 
the dose statistics including RTOG metrics, dose to OARs 
in a lung SBRT plan besides reduced treatment time. In the 
second alternate planning strategy, photon energy of 6MV was 
replaced by 6 MV-FFF and vice versa. Likewise, 10 MV photon 
beam was replaced by 10 MV-FFF and vice versa.
DVH-based statistics from the two alternate plans were 
compared against DVH of the clinical plan. Plans were 
evaluated according to the following parameters: CI, R
50%
, 
D
2cm
, HDloc, DFG, and dose to OARs.
Statistical analysis
The dose statistics from the alternate plans were compared to 
the clinical plan. Test for normal distribution was performed 
using Shapiro-Wilk test in R statistical software ver 3.2.0 
(R Development Core Team).[14] Statistical significance was tested 
using a paired Student’s t-test for normally distributed data and a 
Wilcoxon signed-rank test, otherwise with a threshold P = 0.05.
results
Radiation therapy oncology group patient plan quality 
metrics
Clinical plan metrics met the RTOG reports 0813,[15] 0915[16] 
guidelines tabulated in Table 2. The CI values have an average 
of 1.1 (range: 0.99–1.24) which is close to the value of 1.2 
for acceptable plan. Based on PTV, the plans should have 
R
50%
 values <3.2–5.3 for an acceptable plan and <4.2–6.3 
for a plan with minor deviation. The observed values of D
2cm
 
ranged within 43.0%–74.1% and are well within the range of 
an acceptable plan or a plan with minor deviation. An ideal plan 
should have values of HDloc <0.15 which was observed in all 
the patient plans. The mean ± SD of DFP was 253 ± 36 for the 
patient plans. Figure 1 shows the relationship of DFP and PTV 
with a slope of −0.016 and R2 of 10−4. Such a small value of 
slope implies a negligible change in DFP with PTVs observed 
in lung tumor patients treated with SBRT at our institution. 
This indicates that DFP is independent of PTV which implies 
that D
2cm
 and R
50%
 may not be independent of each other.
Dosimetry – thorax phantom plan
A thorax phantom plan with multiple rings outside the PTV 
and the ring terminator region is displayed in Figure 2. Linear 
dose profiles outlined in Figure 3 confirms a steeper dose falloff 
along the longitudinal axis than along a lateral side of the 
phantom. Figure 3 also confirms that dose drops off to <10% 
of Rx dose at distances of 1 cm along the longitudinal and 
4 cm along the lateral direction from the PTV surface. These 
were considered as extents of the “ring terminator” region, and 
dose outside this region could be neglected without an impact 
on the dose statistics.
Figure 4 displays the rate of change of slope of the maximum 
dose (measured in cGy/mm2) for the 4 ring widths considered. 
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The huge fluctuations in rate of change in slope observed 
in 2.5 mm ring data hinder their usage. With low spatial 
resolution, the 7.5 mm and 10 mm rings fail to capture the 
trend or curvature of dose falloff outside the PTV. In addition, 
the number of rings has to be sufficient to study the dose 
falloff down to <10% of Rx dose. An optimum choice was 
determined to be 7 rings of 5 mm width. Figure 5 shows the 
maximum and mean dose falloff as well as DFG for 100% 
target coverage.
Dose falloff – patient plans
The maximum and mean dose falloffs with distance from 
PTV were plotted in Figure 6 for patient plans. Using 
Equation 5 to fit the dose falloff, values of the fitting 
coefficients for the maximum dose falloff in the patient 
plans were:
A1 = 65.7 ± 8.1 (%); a1 = 0.094 ± 0.016 (1/mm)
A2 = 50.8 ± 9.7 (%); a2 = 0.006 ± 0.005 (1/mm)
It can be noticed that the values of steep DFG (a1) are larger 
than the slow DFG (a2) by one order of magnitude and the slow 
dose falloff term can be replaced by a constant for distances 
of clinical interest. Notice that although DFG of maximum 
doses decrease with increasing PTV, there is no such trend in 
the DFG of mean doses with PTV.
DFG of the maximum dose was hypothesized to have a trend 
with the intermediate-to-low isodose volumes. The 50% Rx 
isodose volume has been observed to decrease with PTV and 
expected to be lower in a plan with higher DFG. By normalizing 
with the PTV, the volume of normal lung irradiated by 50% 
isodose volume (VNL50%) has been evaluated against DFG. 
Figure 7 displays exponentially decreasing relation of VNL50% 
normalized to PTV with DFG of maximum dose. Note that 
VNL50% is calculated from the intersection of bilateral lungs 
with 50% isodose volume and could be extended to estimate 
V
20
 or mean lung dose. However, R
50%
 calculation could include 
chest wall, ribs, and other organs outside the lungs.
Plan QualIty MetrIcs – alternate Plans
The alternate plans were reoptimized to meet the target 
coverage and OAR dose constraints. Barring R
50%
 of one 
clinical plan, the values of both D
2cm
 and R
50%
 of all the clinical 
plans can be considered acceptable or with minor deviation, as 
shown in Figures 8 and 9, respectively. Among the coplanar 
plans, 4 and 5 patients had major deviations in D
2cm
 and R
50%
, 
respectively. Corresponding numbers for alternate energy plans 
were 4 and 7 patients.
Figure 1: Plot showing the values of dose falloff product with the volume 
of PTV. The solid line represents trend line represented by the equation 
while dashed lines shows twice standard deviation
Figure 2: Cross‑sectional views of a representative patient’s 
volumetric‑modulated arc therapy‑based stereotactic body radiation 
therapy plan showing seven 5 mm wide rings generated concentric with 
the PTV surface. Also seen is the ring terminator with 1 cm gap from the 
superior and inferior extremes of the PTV surface
Table 2: Statistics of the quality metrics from patient plans along with the acceptable range and the number of plans 
outside the scope of a minor deviation, as per Radiation Therapy Oncology Group‑0915 specifications
Minimum Maximum Average SD RTOG‑0915 
acceptable range
RTOG‑0915 minor 
deviation
Number of plans with 
major deviation
CI 0.99 1.24 1.1 0.1 <1.2 <1.5 0
HI 0.1 0.3 0.2 0.1 NA NA NA
R
50%
3.3 6.7 4.6 0.7 <3.2-5.3 <4.2-6.3 1
D
2cm
43.0 74.1 55.0 6.8 <50.0-71.7 <57.4-90.1 0
HDloc 0.0 0.1 0.01 0.02 <0.15 NA 0
DFP 189 333.5 253 35.9 NA NA NA
HI: Homogeneity index, CI: Conformity index, DFP: Dose falloff product, HDloc: High-dose spillage, NA: Not available, SD: Standard deviation, 
RTOG: Radiation Therapy Oncology Group
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Statistical significance – alternate plans
None of these metrics (CI, HI, HDloc, D2cm, and R50%) of the 
alternate plans displayed significant differences with the 
clinical plans at 5% threshold.
dIscussIon
The analysis of SBRT plans of lung tumor showed that R
50%
 
and D
2cm
 were, respectively, decreasing and increasing with 
PTV. Similar values of R
50%
 and D
2cm
 were reported by a 
phase III multicenter randomized trial (ROSEL) on Stage 1A 
lung cancer.[17] To the best of our knowledge, this is the first 
study which revealed that the product of these two metrics, 
DFP has slowly varying value which questions the complete 
independence of R
50%
 and D
2cm
. This study questions the need 
to have two metrics when either one could perform this job 
equally well. It is evident from Figures 8 and 9 that RTOG 
constraints on D
2cm
 can be easier to meet than those of R
50%
, 
thereby suggesting that R
50%
 is possibly a superior metric.
In this study, the dose falloff outside PTV in lung SBRT plans 
that take the spatial dose distribution was taken into account. 
Our analysis shows that asymmetric dose distribution, possibly 
due to beam arrangement or avoidance structures, can be 
quantified by DFG derived from Equation 5. The contrasting 
dose falloff along axial and longitudinal axes illustrated in 
Figure 3 agrees with similar results from an extracranial 
SBRT study.[13] The authors studied the isotropicity of dose 
distribution and gradient of dose falloff in regions adjacent 
and away from the tumor boundary. For a target with 
significant longitudinal movement seen in lung tumors, this 
dose distribution presents a potential risk of marginal miss, 
especially when small PTV margins are used.
Equation 5 is a fitting function for the dose distribution in the 
region outside PTV. For the 41 plans studied here, V50% of 
normal lung normalized by the PTV was found to decrease 
exponentially with DFG of maximum dose. From a known 
DFG, one can estimate VNL50% or any intermediate dose 
including, V
20
. Thus, DFG can be used as a surrogate of normal 
lung irradiation with high DFG symbolizing low percent of 
normal lung irradiated by intermediate dose, as shown in 
Figure 7. Although not considered during plan optimization, 
the radial dose dependence dropoff measured by DFG can be 
used as a complementary measure.
Alternate treatment plans were created to study the effect of 
beam arrangement and beam energy on dose reduction to 
normal tissue. In a 37 lung cancer patient SBRT study, Lim 
et al. found that multiple noncoplanar static fields produce 
significantly lower R
50%
 than multiple coplanar static fields or 
VMAT.[18] In a retrospective study on 15 lung cancer patients, 
VMAT plans scored substantially better RTOG metrics than 
3D plans, and noncoplanar VMAT plans were slightly better 
than coplanar VMAT plans.[19] In our study, 4 and 5 coplanar 
plans had a major deviations in D
2cm
 and R
50%
, respectively, 
while the corresponding numbers were 1 and 0 in noncoplanar 
plans. However, a significant gain in dose to OARs or RTOG 
metrics was not observed in our study using noncoplanar arcs 
(P > 0.1 in Wilcoxon signed-rank test). Possible explanations 
could be the amount of noncoplanarity from about ± 15° couch 
angle limitation due to collision issues and lack of statistical 
power. It is feasible to achieve better results on lateral tumors 
and smaller sized patients where the couch angle could be 
larger. The main advantage of noncoplanar arc and FFF beams 
is the ability to spare critical organs with additional degrees 
Figure 4: Rate of change of slope of the maximum dose (cGy/mm2) for 
the 4 ring widths in thorax phantom
Figure 3: Point dose falloff along the (a) right and (b) superior direction as a function of distance from the PTV surface in a patient plan shows moderate 
and steep gradient, respectively
ba
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of freedom.[20,21] Zhang et al. had demonstrated slightly better 
RTOG metrics for noncoplanar VMAT plans with FFF beams 
than their flattened counterpart beams, with the exception of 
number of monitor units.[19] Higher MUs in FFF beams does 
not necessarily imply large peripheral doses due to lower 
head leakage with the absence of flattening filter. In fact, 
Figure 6: (a) Maximum dose falloff (%) from the PTV surface and (b) maximum dose falloff gradient (1/mm) as a function of PTV volumes in the patient 
plans. (c) Mean dose falloff (%) from the PTV surface and (d) mean dose falloff gradient (1/mm) as a function of PTV volumes in the patient plans
dc
ba
Figure 5: (a) Maximum dose falloff (%) from the PTV surface and (b) maximum dose falloff gradient (1/mm) as a function of PTV volumes in the thorax 
phantom. (c) Mean dose falloff (%) from the PTV surface and (d) mean dose falloff gradient (1/mm) as a function of PTV volumes in the thorax phantom
dc
ba
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when treating with FFF-VMAT plan, the percent of normal 
lung exceeding 5 Gy and 20 Gy (V5 and V20, respectively) 
were lower,[22] both of which were correlated to pneumonitis. 
The dose rate of FFF beams is substantially higher than 
conventional beams leading to lower treatment time and less 
chances of patient motion. In a 132 lung cancer patient study, 
Navarria et al. had concluded that SBRT with FFF beams 
permitted safe delivery of high dose per fraction in a short 
treatment time resulting in an earlier radiological response 
compared with FF beams.[23]
conclusIons
An exponential fit function was attempted to study the 
dose distribution outside the PTV from which dose falloff 
coefficients, namely, DFG were extracted. This new variable 
was used to evaluate dose to the normal tissue outside the 
PTV and could act as an SBRT DFG in addition to other 
metrics. In addition, DFG could be used to predict the percent 
of normal lung receiving medium-to-intermediate dose. The 
independence of RTOG recommended metrics, R
50%
, and D
2cm
 
was found to be questionable, although further research is 
required for conclusive evidence.
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